Buradasınız

Anasayfa » Content

Diabetes mellitusun koroner arter bypass cerrahisinde erken dönem morbidite ve mortaliteye etkisi

Effect of diabetes mellitus on short-term morbidity and mortality in coronary artery bypass surgery

Journal Name:

  • Süleyman Demirel Üniversitesi Tıp Fakültesi Dergisi

Publication Year:

  • 2006

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Currently, 15 %to30% of the patients that undergo coronary artery bypass grafting (CABG) are diabetics. However, the effect of diabetes mellitus (DM) on short-term morbidity and mortality after CABG is controversial. The aim of this retrospective study was to investigate whether DM increases short-term morbidity and mortality after CABG or not. Two-hundred-fourty-eight patients who underwent CABG operations in our clinic between June 2003 and September 2005 were included in the study. Mean age of the patients was 59.8 + 9.75 and there were 187 male (% 76) and 59 female (% 23.9). Seventy-nine patients (% 32.1) were diabetic (DM group) and 167 patients (% 67.8) were nondiabetic (control group). The groups were compared for morbidity data and mortality rates in the postoperative short-term. When the groups were compared for the incidence of intra aortic balloon pumping, acute renal failure, multi organ failure, cerebro vascular complications, superficial wound infection, sternal dehiscence, mediastinitis and reoperation due to mediastinal bleeding, there were no statisticaly significant difference (p > 0.05). Mortality rates in the DM group and the control group were %3.7 and %4.7, respectively but there were no statisticaly significant difference (p > 0.05). The incidence of superficial wound infection were significantly higher in the patients with insulin-treated DM than both in the patients with oral antidiabetic-treated DM and in the nondiabetic patients (p = 0.066). In conclusion, in this study we found that DM does not significantly increase short-term morbidity and mortality in the patients who undergo CABG. Provided that strict measures are taken against infections, CABG can be performed in diabetic patients as safely as it is being performed in nondiabetic patients.
Bookmark/Search this post with
Abstract (Original Language): 
Günümüzde, koroner arter bypass cerrahisi (KABC) uygulanan hastaların % 20-30'u diyabetikdir. Bununla birlikte, diabetes mellitus (DM)'un KABC sonrası erken dönem mortalite ve morbiditeye olan etkisi tartışmalıdır. Bu retrospektif çalışmanın amacı, DM'un KABC uygulanan hastalarda erken dönem morbidite ve mortaliteyi anlamlı derecede arttırıp arttırmadığını araştırmaktır. Haziran 2003 ile Eylül 2005 tarihleri arasında kliniğimizde KABC uygulanan toplam 246 hasta çalışmaya alındı. Çalışmaya alınan hastaların ortalama yaşı 59.8 + 9.75 olup 187'si erkek (% 76) ve 59'u kadın (% 23.9) idi. DM tanısı olan 79 (% 32.1) hasta DM grubunu, diğer 167 (% 67.8) hasta da kontrol grubunu oluşturdu. Gruplar, postoperatif erken dönemde morbidite verileri ve mortalite oranı açısından birbiri ile karşılaştırıldı. İntra aortik balon pompası, akut böbrek yetmezliği, multi organ yetmezliği, serebro vasküler olay, yüzeyel yara yeri enfeksiyonu, sternal dehissens, mediastinit ve mediastinal kanama nedenli reoperasyon oranları açısından gruplar birbiri ile karşılaştırıldığında istatistiksel olarak anlamlı fark bulunmadı (p > 0.05). Mortalite oranları DM grubunda % 3.7, kontrol grubunda ise %4.7 idi ve aradaki fark istatistiksel olarak anlamlı değildi (p > 0.05). Yüzeyel yara yeri enfeksiyonu oranı, insülin kullanan diyabetik hastalarda, hem oral antidiyabetik kullanan diyabetik hastalara hem de kontrol grubuna göre anlamlı derecede daha yüksekti (p = 0.066). Sonuç olarak, bu çalışmada, DM'un KABC uygulanan hastalarda erken dönem morbidite ve mortaliteyi anlamlı derecede arttırmadığını bulduk. KABC, enfeksiyona karşı azami önlemler alınarak, diyabetik olan hastalarda da diyabetik olmayan hastalarda olduğu gibi güvenle uygulanabilir.
FULL TEXT (PDF): 
PDF icon arastirmax-diabetes-mellitusun-koroner-arter-bypass-cerrahisinde-erken-donem-morbidite-mortaliteye-etkisi.pdf
  • 1
16-21
  • Turkish

REFERENCES

References: 

1. Fukushima H, Sugiyama S, Honda O, Koide S, Nakamura S, Sakamoto T et al. Prognostic value of remnant-like lipoprotein particle levels in patients with coronary artery disease and type 2 diabetes mellitus. J Am Coll Cardiol 2004;43:2219-24.
2. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998:339:229-34.
3. Nobless-James C, James EA, Sowers JR. Prevention ofcardiovascular complications ofdiabetes mellitus by aspirin. Cardiovasc Drug Rev 2004;22:215-26.
4. Frye RL, Bell MR, SchaffHV, Holubkov R, Detre KM. The role ofPCI and CABG in the management ofcoronary artery disease in patients with diabetes. Curr Diab Rep 2002;2:16-20.
5. Carson JL, Scholz PM, Chen AY, Peterson ED, Gold J, Schneider SH. Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol
2002;40:418-23.
6. Thourani VH, Weintraub WS, Stein B, Gebhart SSP, Craver JM, Ellis LJ et al. Influence ofdiabetes mellitus on early and late outcome after coronary artery bypass grafting. Ann Thorac Surg 1999;67:1045-52.
7. Salomon NW, Page US, Okies JE, Stephens J, Krause AH, Bigelow JC. Diabetes mellitus and coronary artery bypass. Short-term risk and long term prognosis. J Thorac Cardiovasc Surg 1983;85:264-71.
8. Risum O, Abdelnoor M, Svennevig JL, Levorstad K, Gullestad L, Bjornerheim R. Diabetes mellitus and morbidity and mortality risks after coronary artery bypass surgery. Scand J Thorac Cardiovasc Surg 1996;30:71-5.
9. Szabo Z, Hakanson E, Svedjeholm R. Early postoperative outcome and medium-term survival in 540 diabetic and 2239 nondiabetic patients undergoing
S.D.Ü. Tıp pak.
Derg
. 2006:13(1)/ 16-21
Kiriş, Diabetes Mellitus ve Koroner Bypass Cerrahisi
21
coronary artery bypass grafting. Ann Thorac Surg 2002;74:712-9.
10. Cohen Y, Raz I, Merin G, Mozes B. Comparison of factors associated with 30-day mortality after coronary artery bypass grafting in patients with versus without diabetes mellitus. Am J Cardiol 1998;81:7-11.
11. Herlitz J, Wognsen GB, Karlson BW, Sjöland H, Karlsson T, Caidahl K et al. Mortality, mode ofdeath and risk indicators for death during 5 years after coronary artery bypass grafting among patients with and without a history ofdiabetes mellitus. Coron Artery Dis 2000;11:339-346.
12. Charvat J, Stritesky M, Semrad M, Vanek I, Kvapil M, Vanecek T. Comparison of short-term and long-term results after aortocoronary bypass in ischemic heart disease in diabetics and non-diabetics. Vnitr Lek
2002;48:279-84.
13. Woods SE, Smith JM, Sohail S, Sarah A, Engle A. The influence oftype 2 diabetes mellitus in patients undergoing coronary artery bypass surgery. Chest 2004;126:1789-1795.
14. Calafiore AM, Mauro MD, Giammarco GD, Contini M, Vitolla G, laco AL et al. Effect ofdiabetes on early and late survival after isolated first coronary bypass surgery in multivessel disease. J Thorac Cardiovasc Surg2003;125:144-154.
15. Morricone L, Ranucci M, Denti S, Cazzaniga A, Isgro G, Enrini R et al. Diabetes and complications after cardiac surgery: comparison with a non-diabetic population. Acta Diabetol 1999;36:77-84.
16. Brandt M, Harder K, Walluscheck KP, Fraund S, Böning A, Cremer J. Coronary artery bypass surgery in diabetic patients. J Card Surg 2004;19:36-40.
17. Luciani N, Giuseppe N, Gaudino M, Abbate A, Glieca F, Alessandrini F, et al. Coronary artery bypass grafting in type 2 diabetic patients: a comparison between insulin-dependent and non-insulin-dependent patients at short- and mid-term follow-up. Ann Thorac Surg 2003;76:1149-54.
18. Kapur A, Malik IS, Bagger JP, Anderson JR, Kooner JS, Thomas M, et al. The coronary artery revascularisation in diabetes (CARDia) trial: background, aims, and design. Am Heart J 2005;149:13-
9.
19.
Ciha
n H B, Erdil N, Nisanoğlu V, Çolak C, Erdil F, Ege E ve ark. Koroner bypass cerrahisinde tip 2 diabetes mellitus mortalite ve morbiditeyi arttırır mı? Türk Göğüs Kalp Damar Cer Derg 2005;13:93-98.
20. Swenne CL, Lindholm C, Borowiec J, Carlsson M. Surgical-site infections within 60 days of coronary artery by-pass graft surgery. J Hosp Infect 2004;57:14-
24.
21. Barxton JH, Marrin CA, McGrath PD, Morton JR, Norotsky M, Charlesworth DC et al. 10-year follow-up ofpatients with and without mediastinitis. Semin
Thorac Cardiovasc Surg 2004;16:70-6.
22. Zacharias A, Habib RH. Factors predisposing to median sternotomy complications: deep vs superficial infection. Chest 1996;110:1173-78.
23. Clement R, Rousou JA, Engelman RM, et al. Perioperative morbidity in diabetics requiring coronary arterybypass surgery. Ann Thorac Surg 1988;46:321-
323.

Thank you for copying data from http://www.arastirmax.com